Company Data
NKGen Biotech Inc.
Ticker
NKGN
Current Price
$0.3011 0.33%
Market Cap
$13.5M
Price Target
Refer to Report
Volume
141.4K
52wk Range
$0.0983 - $1.37
Overview
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system.